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Abstract P2X receptors are ion channels gated by extracellular 
ATP. We report here cloning of a P2X2 receptor splice variant 
(P2X2_2) carrying a 207 bp deletion in the intracellular C-
terminus and the analysis of the corresponding genomic structure 
of the P2X2 gene. P2X2_2 is as highly expressed as the original 
P2X 2 sequence in various tissues. ATP-activated currents 
mediated by heterologous expressed P2X2 or P2X2_2 receptors 
showed significant differences in desensitization time constants 
and steady-state currents in the continuous presence of ATP. 
These results imply functional differences between cells differ-
entially expressing these P2X2 isoforms. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
P2X receptors are ion channels gated by extracellular ATP. 
They are expressed in a broad variety of tissues and known to 
mediate fast synaptic transmission [7,8] and synaptic trans-
mission between sympathetic nerves and smooth muscle 
[9,19]. By now 7 P2X receptor subunits (P2X!-P2X 7 ) have 
been cloned which share a putative two-transmembrane seg-
ment structure with intracellular C- and N-termini and an 
extracellular loop [2,3,5,6,14,20,21]. Heterologous expression 
of each subunit results in the formation of non-selective cation 
channels with differential sensitivities for the agonists A T P 
and a,|3-methylene-ATP and the antagonists pyridoxal-5-
phosphate-6-azophenyl-2',4'-disulfonic acid (PPADS) and 
suramin. They also differ in their time constant of desensitiza-
t ion: P2Xi and P2X3 are fast desensitizing while P2X2 and 
P2X4 to P2X7 show a much slower desensitization. 
Here we report the cloning of a splice variant (P2X2_2) of 
the P2X2 receptor subtype and the identification of the corre-
sponding rat genomic sequence. We used heterologous expres-
sion of the P2X2 and P2X2_2 receptor to look for functional 
differences between both isoforms. 
2. Materials and methods 
2.1. RT-PCR analysis 
Total RNA from brain, spleen, kidney, intestine and organ of Corti 
was isolated from adult Wistar rats (Charles River, Germany) with 
the RNeasy Total RNA-Kit (Qiagen, Chatsworth, CA). First strand 
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cDNA was synthesized from 1 ug total RNA using an oligo d(T) 
primed 20 jo.1 reaction by the Superscript RNase H-Reverse transcrip-
tase (Life Technologies Inc., Gaithersburg, MD) under standard con-
ditions [1]. 
PCR amplification of a P2X2-specific fragment was performed us-
ing the following primers: sense primer (up2: 5'-ATTCGCA-
CAGGGCACTGTGTACC-3', positions 424-146) and antisense pri-
mer (lo2: 5'-TTAGCAGCCAAAGCTGTCTCT-3', positions 1460-
1480) resulting in a 1056 bp fragment. Nested PCR: sense primer 
(up3: 5'-GCCTGGTGCCCGGTGGAG-3', positions 484-501), anti-
sense primer (lo2) resulting in a 955 bp fragment. 
The PCR amplifications were performed on a GeneAmp PCR Sys-
tem 9600 thermal cycler (Perkin Elmer, Norwalk, CT) under standard 
conditions [18] using 1 (il of the first strand cDNA in a final volume of 
50 u.1, 1 U AmpliTaq (Perkin Elmer) and a primer concentration of 40 
ng/(il. Reaction conditions for the first and second round of amplifi-
cation were 45 cycles of 30 s 94°C, 30 s 60°C and 30 s 72°C starting 
with 3 min at 94°C and ending with an extension of 5 min at 72°C. 
The reaction products were at first analyzed by gel electrophoresis. 
Identity of the PCR products was tested by Southern blot analysis 
using a 165 bp PCR fragment of the P2X2 receptor sequence as a 
hybridization probe (positions 519-684). In addition PCR products 
were gel-isolated and, after blunting with kinase, subcloned in an 
EcoRV cut, dephosphorylated pBluescript vector (Stratagene, La Jol-
la, CA). Sequences of the recombinant fragments were determined on 
both strands by fluorescent DNA sequencing (Applied Biosystems 
Inc., Foster City, CA). 
2.2. Genomic organization of the P2X2 receptor gene 
Genomic DNA was isolated from rat liver using the QIAamp Tis-
sue Kit (Qiagen, Chatsworth, CA). To identify the genomic P2X2 
receptor sequence two overlapping fragments were amplified from 
the start codon to 61 bp downstream of the stop codon (3'UT region) 
of the published P2X2 receptor sequence [2]. The primer pair for the 
amplification of the 5' fragment was: sense primer (upl: 5'-
GCCATGGTCCGGCGCTT-3', bp -3-14) and antisense primer 
(lol: 5'-GGCTGACACCTCGCAGGTCTT-3', bp 466-486); to am-
plify the second fragment the primer pair up2/lo2 (as described in 
Section 2.1) was used. The PCR conditions were 45 cycles of 1 min 
94°C, 1 min 60°C and 1 min 72°C starting with 3 min at 94°C and 
ending with an extension of 5 min at 72°C. The fragments were 
subcloned as described in Section 2.1. The recombinant cloned 
DNA was denatured by NaOH and sequenced on both strands using 
Sequenase Version 2.0 Kit (Amersham/USB, Cleveland, OH). For 
both fragments 10 independent clones were analyzed, showing identi-
cal sequences. 
2.3. Expression of P2Xi isoforms in Xenopus oocytes and HEK293 
cells 
For functional expression a full-length P2X2_2 receptor clone was 
constructed. The HpaVXhol restriction fragment of the original P2X2 
receptor clone [2] in pcDNA 3 (Invitrogen, San Diego, CA) was sub-
stituted by the corresponding fragment of the subcloned isoform car-
rying the deletion. The identity of the resulting P2X2_2 clone was 
verified by sequencing. 
Capped cRNAs specific for P2X2 and P2X2_2 were synthesized in 
vitro using T7 polymerase (Stratagene capping kit) and injected into 
Xenopus oocytes. 
Handling and injection of Xenopus oocytes has been described pre-
viously [10]. 24 h after injection oocytes were treated with collagenase 
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type II (Sigma, 0.5 mg/ml) for 45 min. After collagenase treatment the 
follicle cell layer was removed manually with fine forceps. Oocytes 
were defolliculated carefully as follicular oocytes are known to have 
intrinsic P2 receptors [12]. Not injected defolliculated oocytes from 
every donor animal were tested for endogenous ATP-activated cur-
rents which have been described previously to be activated at agonist 
concentrations > 100 uA [12,13]. Similar to the observations of King 
et al. [12] we found these endogenous ATP-activated currents in only 
one batch of oocytes excised from one of 20 donor frogs. This batch 
of oocytes was not used. Electrophysiological recordings were per-
formed 3-7 days after injection using a two-microelectrode voltage 
clamp. Current and voltage electrodes were pulled from thick-walled 
borosilicate glass. They were filled with 3 M KC1 and had resistances 
between 0.1 and 0.5 Mfl. Currents were recorded with a TurboTec 
01C amplifier (npi, Tamm, Germany), digitized at 30 Hz (ITC16, 
HEKA, Lamprecht, Germany) and stored on the hard disk. The 
bath chamber was made up as a narrow canal to achieve complete 
solution exchanges in less than 3 s. The extracellular solution was 
composed of (in mM): NaCl 115, KC1 2.5, MgCl2 1.8, HEPES 10; 
pH adjusted to 7.3 with NaOH. All experiments were performed at 
room temperature (approximately 23°C). To exclude that the decline 
of current during ATP application is due to a channel block mediated 
by extracellular divalent cations, we elicited ATP-activated currents in 
an extracellular solution with the divalent cations substituted by poly-
vinylpyrrolidone (Boehringer Mannheim) [16]. Under these conditions 
the ATP-activated currents declined with the same time course as in 
extracellular solutions containing Ca2+ or Mg2+ . 
The HEK293 cells were transiently transfected with the cDNA 
encoding P2X2 or P2X2_2 using lipofectin (Life Technologies Inc.) 
as previously described [14]. Conventional whole-cell recording 
and fast-flow U-tube agonist application methods were used. Internal 
pipette solution was (mM): KC1, K-aspartate or Cs-aspartate 140, 
NaCl 20, EGTA 10 and HEPES 5. Extracellular solution was 
(mM): NaCl 147, KC12 2, CaCl2 2, MgCl2 1, HEPES 10 and glucose 
12; pH was adjusted to 7.35 with NaOH. ATP (magnesium salt), a,(5-
methylene-ATP (lithium salt) and PPADS were purchased from 
Sigma (St. Louis, MO) and suramin from Bayer (Leverkusen, Ger-
many). 
A 
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3. Results 
3.1. Detection and cloning of the P2X2-2 receptor isoform 
Various rat tissues were tested for P2X2 receptor expression 
with PCR using a P2X2-specific primer pair (up2/lo2) (Fig. 
1A). The PCR products resulted in three distinct bands of 
995 bp, 910 bp and 790 bp length in the gel electrophoresis. 
All three bands showed hybridization with a P2X2-specific 
probe in Southern blot analysis. For identification of the se-
quences the fragments were isolated, subcloned and se-
quenced. The largest band with 995 bp yielded the original 
P2X2 sequence [2]. 
The smallest band with 790 bp revealed a 207 bp in-frame 
deletion in the C-terminal region at nucleotide positions 1111-
1317 of the original P2X2 sequence (Fig. 2). 
Similarly, a RT-PCR reaction on brain RNA with primers 
(upl/lo2) covering the whole coding region of P2X2, besides 
the expected 1483 bp fragment, yielded an approximately 200 
bp shorter fragment (not shown). This suggests that the 207 
bp deletion is a naturally occurring variant of the P2X2 re-
ceptor possibly generated by alternative splicing. 
Subcloning and sequencing of the intermediate band yielded 
either the sequence of the original or that of the 207 bp de-
leted form. Control PCRs with cloned DNA of the original 
P2X2 sequence and the 207 bp deletion mixed in a 1:1 relation 
also resulted in three bands in gel electrophoresis. Therefore 
we interpret this band as a PCR artefact (Fig. IB; see Section 
4). 
3.2. Genomic structure of the P2Xi receptor gene 
To obtain the genomic organization and putative splice sites 
6 
Fig. 1. A: Tissue distribution of P2X2 isoforms detected by RT-PCR. The PCR yielded three products with 995 bp, 910 bp and 790 bp frag-
ment length, respectively. The positive control was cloned P2X2 DNA. As marker a 100 bp ladder was used. B: PCR using a mixture of the 
cloned P2X2 sequence and the 207 bp deleted isoform resulted in the same 3 fragments as in A. 
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Fig. 2. A: Genomic structure of the rat P2X2 gene. Eleven exons are shown with deduced amino acid sequences indicated below. The exon-in-
tron borders are indicated by the corresponding base pair numbers, the 10 intron sequences are written in small letters. The transmembrane do-
mains TMl and TM2 and the spliced region of the P2X2-2 isoform are shown in frames. The positions of primers are indicated by arrows. 
The sequence has been deposited in the EMBL data base under accession number Y09910. B: Organization of the P2X2 receptor gene. The po-
sition of the introns (I-X) is indicated by the nucleotide number of the P2X2 receptor coding region (A of ATG = 1). The putative transmem-
brane domains (TMl and TM2) and the deleted region of the P2X2-2 isoform are indicated. 
of the P2X2 receptor gene we amplified two overlapping PCR 
fragments covering the coding region of the rat P2X2 receptor 
gene (Fig. 2A). The resulting genomic sequence with 2830 bp 
compared to 1481 bp of the P2X2 receptor cDNA includes 10 
introns ranging in size from 78 to 320 bp, most of them in the 
100 bp range (Fig. 2B). Interestingly, the 207 bp deletion of 
the P2X2 receptor isoform, which we detected in various 
tissues coexpressed with the P2X2 receptor, is not flanked 
by introns but by consensus sequences for splice sites 
which induce splicing of a fragment directly out of an exon 
[15]. 
3.3. Functional expression of the P2X2_2 receptor 
Both isoforms of the P2X2 receptor were expressed in Xe-
nopus oocytes and HEK293 cells. Fig. 3 shows ATP-activated 
currents investigated in defolliculated oocytes with the two-
microelectrode voltage clamp technique at a holding potential 
of - 7 0 mV. 
300 uM ATP applied for 1 min elicited inward currents 
with amplitudes of 2.1 ± 1.0 uA (mean ± S.D.; n = 8) in P2X2 
injected oocytes and of 5.5 ±3.1 uA («=12) in P2X2_2 in-
jected oocytes. Comparing the ATP-activated currents of 
both clones we found a significantly faster desensitization of 
the P2X2_2 receptor with desensitization time constants of 
T = 1 2 ± 1 s (rc=12) compared to the P2X2 receptor with 
T = 56±6 s (« = 8) (P< 10"7 revealed by Student's Mest). 
Steady-state current amplitudes of the ATP-activated 
currents (Is; measured as remaining current amplitude com-
pared to the maximum current amplitude) were evaluated 
during application of 300 uM ATP for 5-15 min. P2X2 
receptor currents desensitized to steady-state currents of 
Is = 7.4 ± 3.4% (« = 9) whereas P2X2_2 receptor currents desen-
sitized to significantly smaller current amplitudes of 
Is = 0.9 ± 0.3% (n = 8) (P < 0.0005). 
The pharmacological properties of the P2X2_2 receptor 
were measured in HEK293 cells using whole-cell recording 
at a holding potential of —75 mV. There was no obvious 
difference compared with the P2X2 receptor. ATP induced 
concentration-dependent inward currents with a maximal re-
sponse observed at 300 (J.M; half-maximal concentration 
(EC50 value) was 7.8 ±2.1 uM and Hill slope was 1.7 ±0.12 
(mean ± S.E.M.; n = 9). a,|3-Methylene-ATP (10-300 uM) was 
virtually inactive as an agonist at this receptor. Currents in-
duced by 30 uM ATP were inhibited nearly completely by 
suramin (1-10 uM) and PPADS (10 uM). 
4. Discussion 
In this paper we describe cloning and functional expression 
of the splice variant P2X2_2 of the P2X2 receptor character-
ized by a 207 bp deletion in the C-terminus. We also report 
the cloning of the P2X2 receptor genomic sequence which 
consists of 11 exons comprising the published cDNA sequence 
[2] and 10 introns (Fig. 2B). Analysis of splice donor and 
acceptor sequences showed that all intronic sequences except 
that of intron II fit to the extended GT-AG rule with the 
consensus sequences C/AAG | G T A / G A G T (for splice donor se-
quence) and ( T / C ) I I N C / T A G | G (for splice acceptor sequence) 
[15]. In the P2X2 receptor genomic sequence the 207 bp dele-
tion in the C-terminus is not flanked by any intronic sequence 
but the splice junction sites of the deleted fragment are 
flanked by sequences fitting to the extended GT-AG rules. 
The 207 bp deletion is spliced out of a genomic region which 
codes for an exon of the P2X2 receptor. 
A recently published truncated form of the P2X2 receptor 
[11] carries a 85 bp insertion containing a stop codon which is 
identical to intron X of the genomic sequence. This isoform 
was detected in pituitary gland and stria vascularis of the 
inner ear, but no functional expression has been shown. How-
ever, the large number of exon-intron borders suggests the 
existence of further P2X2 receptor splice variants. 
P2X2-specific RT-PCR yielded the P2X2 and P2X2_2 frag-
ments and a third band of 910 bp length besides. Neither 
subcloning nor direct sequencing of this band repeated for 
several times resulted in any sequence information with the 
expected size. The 910 bp band could not be eliminated by 
changing PCR conditions. Different annealing temperatures, 
numbers of PCR cycles and primer concentrations have been 
tested. Control PCRs using a mixture of cloned P2X2 and 
P2X2_2 DNA also resulted in three bands (Fig. IB). Therefore 
we suggest that the 910 bp band may represent an artefact 
created by an interaction of the P2X2 isoforms. 
All tissues tested in this study using RT-PCR showed an 
expression of both isoforms (Fig. 1A) with a tendency to a 
stronger expression of the P2X2_2 receptor. 
Functional comparison of the P2X2 and P2X2_2 variants 
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P2X2 
300 ^M ATP 
U. Brandle et al.lFEBS Letters 404 (1997) 294-
P2X2-2 
300 iiM ATP 
20 s 
x = 57s 
x = 56 ± 6 s (n = 8) 
20 s 
x = 11 s 
x = 12±1 s(n = 12) 
Fig. 3. Functional expression of the P2X2_2 receptor and comparison with P2X2. 300 u.M ATP elicited inward currents which differed signifi-
cantly in time constants of desensitization (mean ± S.D.) between the two isoforms. The recordings were made in Xenopus oocytes with two-
electrode voltage clamp at a holding potential of —70 mV. 
revealed significant differences. ATP-activated currents medi-
ated by the P2X2-2 receptor desensitized faster than P2X2-
mediated currents. Desensitization was nearly complete for 
the P2X2_2 receptor (0.9 ± 0.3%) whereas the P2X2 receptor 
desensitized to a steady-state level of 7.4 ±3.4%. Thus P2X2 
rather than P2X2_2 receptors mediate a steady Ca2+ influx in 
the presence of ATP. This may represent a remarkable func-
tional difference between cells expressing either of the two 
P2X2 isoforms. Differential expression of the P2X2 and 
P2X2_2 variants needs further investigation since in earlier 
studies probes for in situ hybridization, Northern blot analysis 
or antibody staining did not discriminate between them 
[2,11,14]. 
Besides the large difference in desensitization observed be-
tween the two splice variants we observed smaller but also 
significant differences between different batches of oocytes. 
This might be explained by a different level of second mes-
senger regulation of the P2X receptors in different oocyte 
batches. There are several putative PKA/PKC regulation sites 
in the N-terminal and C-terminal regions of the P2X receptor 
sequence which might account for these effects. Some of these 
plus one proline-rich region with an SH3 binding motif for the 
association to cytoskeletal proteins [17] are localized within 
the 207 bp domain spliced out in P2X2-2 which is located 
in the C-terminal intracellular region of the protein. 
Coexpression of the P2X2 and the P2X3 receptor has been 
shown in dorsal root ganglion sensory neurons which transmit 
nociception [4,14]. Intermediate time courses of desensitiza-
tion in ATP-activated currents measured in sensory neurons 
have been explained by heteromultimerization of P2X2 and 
P2X3. Such time courses might also be explained by an in-
volvement of the P2X2-2 receptor. Therefore, to understand 
the basis of important physiological processes like nociception 
the expression pattern, possible heteromultimerization and 
regulation of the P2X2 receptor isoforms need further detailed 
investigation. 
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